EHRLICH JASON 4

4 · Kodiak Sciences Inc. · Filed Jan 24, 2022

Form 4

Period: 2022-01-20

See Remarks

Transactions

Exercise/Conversion
Common Stock
2022-01-20$10.29/sh+6,950$71,516→ 58,491 total
Sale
Common Stock
2022-01-20$62.72/sh−808$50,680→ 57,683 total
Sale
Common Stock
2022-01-20$66.91/sh−198$13,249→ 51,541 total
Sale
Common Stock
2022-01-20$63.55/sh−2,416$153,547→ 55,267 total
Sale
Common Stock
2022-01-20$65.00/sh−2,995$194,689→ 52,272 total
Sale
Common Stock
2022-01-20$66.28/sh−533$35,329→ 51,739 total
Exercise/Conversion
Stock Option (Right to Buy)
2022-01-20−6,950→ 218,538 total
Exercise: $10.29Exp: 2028-08-29→ Common Stock (6,950 underlying)

Footnotes (7)

[F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan.
[F2]The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $62.02 to $62.98, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
[F3]The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $63.135 to $64.11, inclusive.
[F4]The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $64.395 to $65.33, inclusive.
[F5]The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $65.85 to $66.41, inclusive.
[F6]The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $66.91 to $66.99, inclusive.
[F7]Twenty-five percent of the shares subject to the option vested on September 1, 2019, and 1/48th of the shares subject to the option vest on the same day of each month thereafter.

Documents

1 file